Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace narrowed aortic valves that fail to properly open. Following this procedure, however, left ventricular (LV) hypertrophy and myocardial fibrosis persist and are linked to worse prognosis. Renin-angiotensin system (RAS) inhibition can protect against these risks and in response to … [Read more...] about Renin-angiotensin system inhibitors improve TAVR prognosis
Cardiac surgery
AHA 2019: What you need to know
American Heart Association Scientific Sessions, November 16–18, 2019 (Philadelphia, USA) The AHA Scientific Sessions event is the annual meeting of the American Heart Association, considered the number one cardiovascular research and education meeting in the world. ISCHEMIA1: The results of this trial in 5179 higher-risk patients with stable ischemic heart disease … [Read more...] about AHA 2019: What you need to know
Prognostic implication of myocardial injury during PCI vs CABG
Periprocedural myocardial infarction (PMI) is myocardial injury that occurs during revascularization procedures, such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). What remains unclear is the prognostic implications of periprocedural myocardial infarction and the extent of myonecrosis that is prognostically significant. In the … [Read more...] about Prognostic implication of myocardial injury during PCI vs CABG
Top 10 Highlights of TCT 2019
Transcatheter Cardiovascular Therapeutics Congress, September 25–29, 2019 (San Francisco, USA) TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF) and the world’s premier educational meeting specializing in interventional cardiovascular medicine. Valve repair COAPT 3-year outcomes1: 614 patients with heart failure and secondary … [Read more...] about Top 10 Highlights of TCT 2019
Improving survival in patients with advanced heart failure using fully magnetically levitated centrifugal-flow left-ventricular assist devices
The use of left-ventricular assist devices in patients with advanced-stage heart failure is often associated with complications that arise as a consequence of adverse interactions between the device and circulating blood elements. Although bioengineering advances have led to the introduction of durable continuous-flow devices, device malfunction remains a concern. The … [Read more...] about Improving survival in patients with advanced heart failure using fully magnetically levitated centrifugal-flow left-ventricular assist devices